Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH

BACKGROUND: Regulators and clinical experts increasingly recognize the importance of incorporating patient-reported outcomes (PROs) in clinical studies of therapies for pulmonary arterial hypertension (PAH). No PAH-specific instruments have been developed to date in accordance with the 2009 FDA guid...

Descripción completa

Detalles Bibliográficos
Autores principales: McCollister, Deborah, Shaffer, Shannon, Badesch, David B., Filusch, Arthur, Hunsche, Elke, Schüler, René, Wiklund, Ingela, Peacock, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908719/
https://www.ncbi.nlm.nih.gov/pubmed/27301413
http://dx.doi.org/10.1186/s12931-016-0388-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908719/
https://www.ncbi.nlm.nih.gov/pubmed/27301413
http://dx.doi.org/10.1186/s12931-016-0388-6

Ejemplares similares